A randomized trial of multi-factorial primary prevention in high risk subjects candidate to a lung cancer early detection CT program - SMILE

Fondazione IRCCS Istituto Nazionale Dei Tumori0 个研究点目标入组 2,000 人开始时间: 2024年6月19日最近更新: 2024年8月21日

适应症

试验速览

暂无简介。

•Age between 55 and 75 years, Heavy smoker, Eligibility to screening with annual chest CT, Availability and ability to use the Internet via PC, tablet or smartphone, Ability to understand the project to which you intend to participate, No tumors in the last 5 years, Signature of informed consent for enrollment in the study and for the processing of personal data

•Hypersensitivity to acetylsalicylic acid, salicylates or any of the excipients (excipients: cellulose powder, corn starch; coating: copolymers of methacrylic acid, sodium lauryl sulfate, polysorbate 80, talc, triethyl citrate), Serious psychiatric problems, Abuse of alcohol or other substances (even before), Chronic treatment with cardioASA, or other anti-clotting or anti-coagulant drugs (for example: heparin, dicumarol), Treatment with methotrexate, Existing Mastocytosis, History of asthma induced by the administration of salicylates or substances to similar activity, particularly non-steroidal antiinflammatory drugs, Gastroduodenal ulcer, Hemorrhagic diathesis, Severe chronic pathology (eg: severe respiratory and / or renal and / or hepatic and / or cardiac insufficiency), Severe kidney failure

发起方